pcDNA3-TLR2-YFP Citations (14)
Originally described in: TLR Signaling PlasmidsUnpublished
Articles Citing pcDNA3-TLR2-YFP
Articles |
---|
CD36 ligands promote sterile inflammation through assembly of a Toll-like receptor 4 and 6 heterodimer. Stewart CR, Stuart LM, Wilkinson K, van Gils JM, Deng J, Halle A, Rayner KJ, Boyer L, Zhong R, Frazier WA, Lacy-Hulbert A, El Khoury J, Golenbock DT, Moore KJ. Nat Immunol. 2010 Feb;11(2):155-61. doi: 10.1038/ni.1836. Epub 2009 Dec 27. PubMed |
TBK1-associated protein in endolysosomes (TAPE) is an innate immune regulator modulating the TLR3 and TLR4 signaling pathways. Chang CH, Lai LC, Cheng HC, Chen KR, Syue YZ, Lu HC, Lin WY, Chen SH, Huang HS, Shiau AL, Lei HY, Qin J, Ling P. J Biol Chem. 2011 Mar 4;286(9):7043-51. doi: 10.1074/jbc.M110.164632. Epub 2010 Dec 28. PubMed |
Oxidized low density lipoprotein induces bone morphogenetic protein-2 in coronary artery endothelial cells via Toll-like receptors 2 and 4. Su X, Ao L, Shi Y, Johnson TR, Fullerton DA, Meng X. J Biol Chem. 2011 Apr 8;286(14):12213-20. doi: 10.1074/jbc.M110.214619. Epub 2011 Feb 16. PubMed |
oxLDL induces inflammatory responses in vascular smooth muscle cells via urokinase receptor association with CD36 and TLR4. Kiyan Y, Tkachuk S, Hilfiker-Kleiner D, Haller H, Fuhrman B, Dumler I. J Mol Cell Cardiol. 2014 Jan;66:72-82. doi: 10.1016/j.yjmcc.2013.11.005. Epub 2013 Nov 14. PubMed |
Identification and functional characterization of nonmammalian Toll-like receptor 20. Pietretti D, Scheer M, Fink IR, Taverne N, Savelkoul HF, Spaink HP, Forlenza M, Wiegertjes GF. Immunogenetics. 2014 Feb;66(2):123-41. doi: 10.1007/s00251-013-0751-4. Epub 2013 Dec 11. PubMed |
Toll-like receptor 2/4 heterodimer mediates inflammatory injury in intracerebral hemorrhage. Wang YC, Zhou Y, Fang H, Lin S, Wang PF, Xiong RP, Chen J, Xiong XY, Lv FL, Liang QL, Yang QW. Ann Neurol. 2014 Jun;75(6):876-89. doi: 10.1002/ana.24159. Epub 2014 May 28. PubMed |
The gammaherpesviruses Kaposi's sarcoma-associated herpesvirus and murine gammaherpesvirus 68 modulate the Toll-like receptor-induced proinflammatory cytokine response. Bussey KA, Reimer E, Todt H, Denker B, Gallo A, Konrad A, Ottinger M, Adler H, Sturzl M, Brune W, Brinkmann MM. J Virol. 2014 Aug;88(16):9245-59. doi: 10.1128/JVI.00841-14. Epub 2014 Jun 4. PubMed |
Chemoproteomics reveals Toll-like receptor fatty acylation. Chesarino NM, Hach JC, Chen JL, Zaro BW, Rajaram MV, Turner J, Schlesinger LS, Pratt MR, Hang HC, Yount JS. BMC Biol. 2014 Nov 5;12:91. doi: 10.1186/s12915-014-0091-3. PubMed |
The innate immune sensor Toll-like receptor 2 controls the senescence-associated secretory phenotype. Hari P, Millar FR, Tarrats N, Birch J, Quintanilla A, Rink CJ, Fernandez-Duran I, Muir M, Finch AJ, Brunton VG, Passos JF, Morton JP, Boulter L, Acosta JC. Sci Adv. 2019 Jun 5;5(6):eaaw0254. doi: 10.1126/sciadv.aaw0254. eCollection 2019 Jun. PubMed |
Pairing Bacteroides vulgatus LPS Structure with Its Immunomodulatory Effects on Human Cellular Models. Di Lorenzo F, Pither MD, Martufi M, Scarinci I, Guzman-Caldentey J, Lakomiec E, Jachymek W, Bruijns SCM, Santamaria SM, Frick JS, van Kooyk Y, Chiodo F, Silipo A, Bernardini ML, Molinaro A. ACS Cent Sci. 2020 Sep 23;6(9):1602-1616. doi: 10.1021/acscentsci.0c00791. Epub 2020 Jul 30. PubMed |
Retinol binding protein 4 primes the NLRP3 inflammasome by signaling through Toll-like receptors 2 and 4. Moraes-Vieira PM, Yore MM, Sontheimer-Phelps A, Castoldi A, Norseen J, Aryal P, Simonyte Sjodin K, Kahn BB. Proc Natl Acad Sci U S A. 2020 Dec 8;117(49):31309-31318. doi: 10.1073/pnas.2013877117. Epub 2020 Nov 19. PubMed |
The impact of episporic modification of Lichtheimia corymbifera on virulence and interaction with phagocytes. Hassan MIA, Keller M, Hillger M, Binder U, Reuter S, Herold K, Telagathoti A, Dahse HM, Wicht S, Trinks N, Nietzsche S, Deckert-Gaudig T, Deckert V, Mrowka R, Terpitz U, Peter Saluz H, Voigt K. Comput Struct Biotechnol J. 2021 Jan 20;19:880-896. doi: 10.1016/j.csbj.2021.01.023. eCollection 2021. PubMed |
Porphyromonas gingivalis induction of TLR2 association with Vinculin enables PI3K activation and immune evasion. Pandi K, Angabo S, Gnanasekaran J, Makkawi H, Eli-Berchoer L, Glaser F, Nussbaum G. PLoS Pathog. 2023 Apr 6;19(4):e1011284. doi: 10.1371/journal.ppat.1011284. eCollection 2023 Apr. PubMed |
ECDD-S16 targets vacuolar ATPase: A potential inhibitor compound for pyroptosis-induced inflammation. Ekchariyawat P, Saengfak R, Sanongkiet S, Charoenwongpaiboon T, Khongpraphan S, Mala S, Luangjindarat C, Munyoo B, Chabang N, Charoensutthivarakul S, Borwornpinyo S, Tuchinda P, Ponpuak M, Pudla M, Utaisincharoen P. PLoS One. 2023 Nov 27;18(11):e0292340. doi: 10.1371/journal.pone.0292340. eCollection 2023. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.